T.MAN Pharmaceutical PCL (BKK:TMAN) Short-Term Debt: ฿870 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:TMAN T.MAN Pharmaceutical PCL BKK:TMAN
18 GF Score
Price ฿10.30
View Full Analysis

What is T.MAN Pharmaceutical PCL Short-Term Debt?

T.MAN Pharmaceutical PCL BKK:TMAN -0.96% 18 Short-Term Debt is ฿870 Mil as of Jun. 2026. GuruFocus rates BKK:TMAN with a GF Score™ of 18/100.

T.MAN Pharmaceutical PCL's Short-Term Debt for the quarter that ended in Jun. 2026 was ฿870 Mil.

T.MAN Pharmaceutical PCL's quarterly Short-Term Debt declined from Dec. 2025 (฿875 Mil) to Mar. 2026 (฿850 Mil) but then increased from Mar. 2026 (฿850 Mil) to Jun. 2026 (฿870 Mil).

T.MAN Pharmaceutical PCL's annual Short-Term Debt increased from Dec. 2023 (฿537 Mil) to Dec. 2024 (฿1,080 Mil) but then declined from Dec. 2024 (฿1,080 Mil) to Dec. 2025 (฿875 Mil).

T.MAN Pharmaceutical PCL Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

T.MAN Pharmaceutical PCL Short-Term Debt Related Terms

T.MAN Pharmaceutical PCL Short-Term Debt Historical Data

* Premium members only.

The historical data trend for T.MAN Pharmaceutical PCL's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T.MAN Pharmaceutical PCL Short-Term Debt Chart

T.MAN Pharmaceutical PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Short-Term Debt
557.00 536.51 1,080.00 875.00

T.MAN Pharmaceutical PCL Quarterly Data
Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 945.00 890.00 875.00 850.00 870.00
BKK:TMAN
18GF Score
T.MAN Pharmaceutical PCL BKK:TMAN
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ฿870 Mil mean?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Short-Term Debt of ฿870 Mil as of Jun. 2026.
Is T.MAN Pharmaceutical PCL's Short-Term Debt too high?
T.MAN Pharmaceutical PCL's current Short-Term Debt is ฿870 Mil. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Short-Term Debt compare to ZTS and UTHR?
T.MAN Pharmaceutical PCL's Short-Term Debt of ฿870 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. T.MAN Pharmaceutical PCL's current Short-Term Debt is ฿870 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Short-Term Debt of ฿870 Mil. The current Short-Term Debt is ฿870 Mil. T.MAN Pharmaceutical PCL's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Short-Term Debt is ฿870 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

T.MAN Pharmaceutical PCL Business Description

Address Bangkhunthian Road, 69/1 Soi Bangkhunthian 14, Samaedum Subdistrict, Bangkhunthian District, Bangkok, THA, 10150
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
18GF Score

Get the complete analysis for BKK:TMAN

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿10.30
Price